Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

NEW YORK – Genomenon said Monday that it has partnered with Limbus Medical Technologies to integrate its Mastermind genomics literature search engine into Limbus' Varvis, a genomics-based clinical diagnostics decision support system.

An initial integration now available allows users of Rostock, Germany-based Limbus' Varvis system to preview published articles relevant to their search, but they have to click over to Mastermind to read the articles. The partners said they are in process of creating a deeper link with Mastermind's application programming interface so that full text will be available within Varvis.

"The deep integration of Mastermind into Varvis is a very logical step in the evolution of our products," Limbus Managing Director Ben Liesfeld said in a statement. "It brings the most rapidly growing collection of scientific genomic literature into the patient-centered Varvis cockpit so that the clinician can view all relevant information for this specific patient at a glance."

Genomenon CEO Mike Klein said that the partnership will empower geneticists and researchers to make more informed decisions. "Our relationship extends Mastermind's global reach, and connecting Mastermind with Varvis provides significant value in cutting turnaround time and increasing diagnostic yield for genetic labs," he said.

In February, Ann Arbor, Michigan-based Genomenon reached an agreement with BC Platforms to integrate Mastermind into the BC|Genome genomic interpretation and analysis platform to support molecular diagnostics and other clinical genomics work, as well as into discovery and insight system BC|Insight on the research side.

Less than a month ago, the firm also closed a $5.3 million financing round.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.